0
0
3/7/23 at 2:25pm
Organization
Multiple Sclerosis News Today
34 words
0
Comments
Immunic's novel RRMS treatment vidofludimus calcium may offer similar efficacy and better safety than approved MS therapies, new data shows.
You are the first to view
https://multiplesclerosisnewstoday.com/news-posts/2023/03/07/actrims-2023-vidofludimus-calcium-rrms-offers-safety-efficacy/
Create an account
or login to join the discussion